Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The EQUIP Study is testing whether high-risk human papillomavirus (hrHPV), the virus that causes most cervical cancers, can be accurately detected from menstrual blood collected at home. People who have been referred for colposcopy after an abnormal Pap or hrHPV test will use the Q-Pad Kit during their period to collect menstrual samples on a special menstrual pad and mail them to a central laboratory for hrHPV testing. The same participants will have a standard cervical sample collected for routine hrHPV testing and will undergo colposcopy as part of their usual care. By comparing hrHPV results from menstrual samples with results from cervical samples and biopsy findings, the study will evaluate how well the Q-Pad hrHPV Test System detects cervical precancer and will also assess how easy and acceptable it is for participants to use this at-home collection method.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Masz co najmniej 25 lat i masz nienaruszoną szyjkę macicy
- •Zostałaś skierowana do kolposkopii ze względu na abnormalny wynik testu Pap lub HPV
- •Twoje okresy menstruacyjne przychodzą regularnie, co 21-35 dni
- •Masz smartfon, adres email i możesz czytać instrukcje aplikacji w języku angielskim
- •Chcesz podpisać zgodę na uczestnictwo w badaniu
- •Zgadzasz się używać prezerwatywy do stosunku z nowym partnerem od zbierania próbki do wizyty kolposkopii
✗ Disqualifies
- •Jesteś w ciąży lub podejrzewasz ciążę
- •Nie chcesz lub nie potrafisz zebrać i wysłać dwie próbki (koszty wysyłki są pokryte)
- •Miałaś leczenie zmian przedrakowych szyjki macicy w ciągu ostatnich 12 miesięcy
- •Już uczestniczysz w tym badaniu lub w innym badaniu do badania rakotwórczego HPV
Simplified criteria — AI translation
Trial details
- Minimum age
- 25 Years
- Last updated (source)
- July 24, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (3)
Planned Parenthood of Southern New England
New Haven, United States
Planned Parenthood North Central States
Minneapolis, United States
Planned Parenthood of Greater Ohio (PPGOH)
Akron, United States
Trial contact
Brian Weinberg, MS
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/26/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.